Abstract

Medical Journal of AustraliaVolume 2, Issue 2 p. 50-55 Symposium MYELOMA* Ronald Penny M.D.(SYD.), B.S., F.R.A.C.P., F.R.C.P.A., Ronald Penny M.D.(SYD.), B.S., F.R.A.C.P., F.R.C.P.A. Department of Immunology, St Vincent's Hospital, Sydney Department of Medicine, University of New South Wales† Associate Professor of Medicine.Search for more papers by this author Ronald Penny M.D.(SYD.), B.S., F.R.A.C.P., F.R.C.P.A., Ronald Penny M.D.(SYD.), B.S., F.R.A.C.P., F.R.C.P.A. Department of Immunology, St Vincent's Hospital, Sydney Department of Medicine, University of New South Wales† Associate Professor of Medicine.Search for more papers by this author First published: 01 July 1974 https://doi.org/10.5694/j.1326-5377.1974.tb93595.xCitations: 1 * This paper was presented at the Jenny Trust Symposium on Leukaemia and Lymphoma which was held at Sydney Hospital on August 3 and 4, 1973. Address for reprints: Professor R. Penny, The University of New South Wales School of Medicine, P.O. Box 1, Kensington, N.S.W. 2033. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume2, Issue2July 1974Pages 50-55 RelatedInformation

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.